Duloxetine API Market Size 2021 Global Overview, Regional Analysis, Size, Share And Forecast To 2027

Duloxetine API Market Size 2021 Global Overview, Regional Analysis, Size, Share And Forecast To 2027


Market Highlights:

Duloxetine API Market Information: by Application (Major Depressive Disorder, Generalized Anxiety Disorder (GAD), Fibromyalgia, Neuropathic Pain, Chronic Musculoskeletal Pain), by Region (Americas, Europe, Asia-Pacific, Others) – Forecast till 2027

The global Duloxetine Active Pharmaceutical Ingredients (API) Market is expected to register a CAGR of 3.52% and is anticipated to reach USD 3,985.0 million by 2023. Active pharmaceutical ingredients (APIs) are used in the manufacturing of pharmaceutical dosage forms such as tablets and capsules. Duloxetine is a serotonin-norepinephrine reuptake inhibitor used in the treatment of depression and anxiety. Additionally, duloxetine API is used to help relieve neuropathic pain in people with diabetes or ongoing pain due to disease conditions such as arthritis, fibromyalgia, and chronic back pain.

The factors such as the rising prevalence of depression, growing penetration of generic drugs, growing cases of anxiety, the growing trend of outsourcing, strong drug pipeline, and increasing demand for newly developed small molecule drugs are expected to drive the market growth during the forecast period.

Key Players:

Some of the players operating in the duloxetine API market include Lupin, Teva Pharmaceutical Limited, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma, Lupin, Zydus Cadila, among others.

Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/7707                                  

Segmentation:

The global duloxetine API market has been segmented into application. Based on application, the market has been segmented into major depressive disorder, generalized anxiety disorder, fibromyalgia, neuropathic pain, chronic musculoskeletal pain, and others. The chronic musculoskeletal pain accounted for a market value of USD 200.0 million in 2017.

Regional Analysis:

Geographically, the Americas is expected to dominate the global duloxetine API market. In this region, North America is expected to dominate the market owing to the increasing incidence of chronic diseases such as psychological disorders, diabetes, increasing government focus on generic drugs, and technological advancements in the manufacturing processes of APIs. In Europe, the market growth is majorly due to the increasing pharmaceutical sector. Additionally, in Europe, countries such as the UK, Germany, and France have a higher demand for API and thereby drive the growth of the overall market. The Asia-Pacific market for duloxetine API is considered to be growing significantly due to the rising healthcare spending and a growing number of contract manufacturing organizations (CMOs). In this region, Japan accounted for a market share of 13.7% in 2017. Moreover, the Middle East and Africa accounted for the least share of the market. The low market share is due to the limited number of companies manufacturing duloxetine API.

Table Of Content:

1 Executive Summary

2 Market Introduction

2.1 Definition 14

2.2 Scope Of The Study 14

2.3 Market Structure 14

3 Research Methodology

3.1 Research Process 15

3.2 Primary Research 16

3.3 Secondary Research 17

3.4 Market Size Estimation 18

3.5 Forecast Model 18

4 Market Dynamics

4.1 Overview 19

4.2 Drivers 19

4.2.1 Rising Rates Of Anxiety Cases 19

4.2.2 Increasing Prevalence Rates Of Depression 20

4.2.3 Increasing Penetration Of Generic Versions Of Drugs 20

4.2.4 Strong Drug Pipeline 20

4.2.5 Growing Demand For Newly Developed Small Molecule Drugs 20

4.2.6 Growing Trend Of Outsourcing 20

4.3 Restraints 21

4.3.1 Changing Economic Conditions In Different Regions 21

4.3.2 Side-Effects Of Duloxetine 21

4.4 Opportunities 22

4.4.1 Advancements In API Manufacturing 22

4.4.2 Patent Expiry Creating Opportunities For Generic And API Manufacturers 22

5 Market Factor Analysis

Continue...

Browse Complete Report @ https://www.marketresearchfuture.com/reports/duloxetine-api-market-7707                                                                            

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com